Value of an Intervention to Enhance Adherence in Glaucoma Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions
Glaucoma
Interventions
DEVICE

TDA adherence monitor for travoprost therapy

monitoring adherence to travoprost therapy

DEVICE

TDA and travoprost monotherapy

Patients will be prescribed travoprost therapy and will be followed up in a standard clinical fashion with a attention placebo at both baseline and 6 months

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Aristotle University Of Thessaloniki

OTHER